Cancer Patients can now be Monitored Using a Smartphone App

With the rapid rise of technology in the field of healthcare, cancer patients can now be monitored remotely with the aid of sensors in their smartphones.

Cancer patients who receive chemotherapy can be remotely monitored with the help of smartphone sensors, it also uses an algorithm to detect signs of worsening based on the changes in patient behavior, reveals a study. //

The findings, published in the Journal of Medical Internet Research, indicate that worsening symptoms during cancer treatments can be detected using smartphones that patients likely already own and use.

Avenue for Precision Cancer Treatment Discovered
Certain drugs are more efficient in one individual than the other. This can be better understood with the key mutation of cancer cells on the N-terminus.

‘The usage of smartphones for monitoring other chronic illness is also being researched on the basis whether they can be as beneficial as they are in the treatment of cancer.’

Real-time estimation of symptoms and side effects could provide an opportunity for doctors to intervene earlier between clinic visits, preventing unnecessary physician or hospital visits and improving patient quality of life.

The study enrolled 14 patients who were undergoing chemotherapy treatment for gastrointestinal cancer at University of Pittsburgh and UPMC Hillman Cancer Center. They were asked to carry a smartphone for four weeks as they went about their daily lives.

Smartphone software developed by the researchers passively and continuously collected data on behavior patterns, such as the number of calls or texts sent and received, smartphone apps used, and the movement and location of the phone.

Exploring New Ways to Overcome Cancer Treatment Resistance
Cancer treatment resistance could be overcomed by new opportunities, reveals study.

As part of the study, the patients were asked to rate the severity of 12 common symptoms, such as fatigue and nausea, at least once a day. They would classify each day as either a "higher-than-average burden," "average burden," or "low burden" day.

Researchers then used the data collected from the smartphone to develop an algorithm that could identify and correlate the patient's "high-symptom," "average-symptom" and "low-symptom" days with 88 percent accuracy.

Potential Therapy Found for Incurable Pediatric Brain Tumor
A new potential drug therapy has been discovered for a rare, incurable pediatric brain tumor by targeting a genetic mutation found in children with cancer.

"We found that on days when the patients reported worse-than-average symptoms, they tended to spend more time being sedentary, moved the phone more slowly, and spent more minutes using apps on the phone," said Carissa Low, Ph.D., assistant professor of medicine and psychology at the University of Pittsburgh, and lead author of the study. "Collecting these objective behavioral measures from smartphone sensors requires no additional effort from patients, and they could prove beneficial for long-term monitoring of those undergoing arduous cancer treatments or those with other chronic illnesses."

The researchers are conducting follow-up studies to determine whether the same passive sensing approach can be used to identify complications following cancer surgery.

New Cancer Imaging Technique Developed from Horse Chestnuts
A radiation responsive esculin-derived molecular gel has been developed from the molecules of horse chestnuts, which aids in improved detection of cancer.

They also are working with health care providers to understand how to integrate this data into the workflow of clinical care.

Source-Eurekalert